£203.99

Food for Huntingtons Disease (Nutrition and Diet Research Pr)

Public Health

Price data last checked 109 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

Same price for 9 weeks. Today is much like next week.

£204 for 66 days straight · last change was Dec 2025

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 622 days • 622 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 622 days • 3 price ranges

Days at Price

Current Price

Price Analysis

Most common range: £153-164 (390 days, 62.7%)

Price range: £153 - £212

Price levels: 3 price ranges over 622 days

Description

Food and Huntington s Disease is another book in a series of books related to the benefits of food on brain function. This book designates the possible beneficial effects of edible natural products and their active materials on Huntington s disease. This is a progressive neurodegenerative disease that could cause uncontrolled movements, cognitive difficulties and emotional disturbances. The aim of this book and its series is to create awareness in general audiences about the dietary perception to reduce the occurrence of Huntington s disease. This may enable a better understanding and possibly reduce the cost on medical bills for patients (approximately $4500/year/person) and the insurance companies. Literature revealed that this disturbing neurodegenerative disorder has a higher prevalence in Europe (3-7 in 100,000), North America (4-5 in 100,000), and Australia than in Asian countries. Studies suggest that mutation in the HD gene and the repeat expansion play an important role in the pathophysiology of this disease. The genetic defect underlying Huntington s disease is unstable, caused by an abnormal CAG expansion within the first exon of the Huntingtin gene (HTT), leading to an expanded polyglutamine (polyQ) track in the HTT protein. This disease is an inherited one. Even though the prevalence rate is moderate, scientists predict that a lot of people possess the possibility of carrying this disease. Mitochondrial dysfunction and oxidative stress could very highly play a role in this disease. In the last decade, the benefits of food on many diseases including brain diseases were explored. This book aims to summarize the recent updates on the benefit of natural edible materials and their active principles on the prevention or delaying of the progression or the management of this disease. The editors feel highly obligated to all the contributors for this initiative. Undeniably, they believe that the information provided in this book would raise the awareness of the readers and could possibly help them to understand the disease process and the benefits of food items on Huntington s disease management.

Product Specifications

Format: hardcover
ASIN: 1536138541
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > General Medical Issues > Public Health
Domain: Amazon UK
Release Date: 13 July 2018
Listed Since: 01 May 2018

Barcode

No barcode data available

Food for Huntingtons Disease (Nutrition and Diet Research Pr)

Same price for 9 weeks. Today is much like next week.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Neurobiology of Huntington's Disease: Applications to Drug Discovery (Frontiers in Neuroscience)

SPEC – Handbook of Clinical Neurology, Volume 144, Huntington Disease, 12-Month Access, eBook (Volume 144)

Neurobiology of Huntington’s Disease: Applications to Drug Discovery (Frontiers in Neuroscience)

Huntington’s Disease: Pathogenic Mechanisms and Implications for Therapeutics

Behavioral Neurobiology of Huntington's Disease and Parkinson's Disease: 22 (Current Topics in Behavioral Neurosciences, 22)

Polyglutamine Disorders: 1049 (Advances in Experimental Medicine and Biology, 1049)

Huntington's Disease: Etiology & Symptoms, Diagnosis & Treatment (Neuroscience Research Progress)

Parkinson's Disease and Related Disorders Part I (Volume 83) (Handbook of Clinical Neurology, Volume 83)

Human Caspases and Neuronal Apoptosis in Neurodegenerative Diseases

Neurotoxic Factors in Parkinson’s Disease and Related Disorders

The Basal Ganglia IX: 58 (Advances in Behavioral Biology, 58)

Springer - Mitochondrial Mechanisms in Parkinson's Disease

Neurodegenerative Diseases: Pathology, Mechanisms, and Potential Therapeutic Targets: 15 (Advances in Neurobiology, 15)

Fractured Minds: A Case-Study Approach to Clinical Neuropsychology

Parkinson's Disease and Related Disorders, Part II (Volume 84) (Handbook of Clinical Neurology, Volume 84)

Caring for Family Members Affected by Huntington?s Disease: The Important Issues for Carers Caring for One or More Family Members Affected by Huntington?s Disease

Micronutrients in Health and Disease, Second Edition

A Theory of the Basal Ganglia and Their Disorders: 8 (Conceptual Advances in Brain Research)

Art and Neurological Disorders: Illuminating the Intersection of Creativity and the Changing Brain (Current Clinical Neurology)

Molecular Pathology of the Prions: 59 (Methods in Molecular Medicine)

Hyperkinetic Movement Disorders (Contemporary Neurology Series)

Handbook of Basal Ganglia Structure and Function (Volume 24) (Handbook of Behavioral Neuroscience, Volume 24)

Protein Misfolding in Neurodegenerative Diseases: Mechanisms and Therapeutic Strategies (Enzyme Inhibitors)

Clinical Studies and Therapies in Parkinson's Disease: Translations from Preclinical Models